KIM-1、Cys C及β2-MG的检测对OSAHS患者早期肾功能损伤的评估及临床意义

张瑞峰, 马建刚, 刘晓晓. KIM-1、Cys C及β2-MG的检测对OSAHS患者早期肾功能损伤的评估及临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(3): 174-179. doi: 10.13201/j.issn.1001-1781.2017.03.003
引用本文: 张瑞峰, 马建刚, 刘晓晓. KIM-1、Cys C及β2-MG的检测对OSAHS患者早期肾功能损伤的评估及临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(3): 174-179. doi: 10.13201/j.issn.1001-1781.2017.03.003
ZHANG Ruifeng, MA Jiangang, LIU Xiaoxiao. The test of KIM-1, Cys C and β2-MG to assess the early renal damage in OSAHS patients and its clinical significance[J]. J Clin Otorhinolaryngol Head Neck Surg, 2017, 31(3): 174-179. doi: 10.13201/j.issn.1001-1781.2017.03.003
Citation: ZHANG Ruifeng, MA Jiangang, LIU Xiaoxiao. The test of KIM-1, Cys C and β2-MG to assess the early renal damage in OSAHS patients and its clinical significance[J]. J Clin Otorhinolaryngol Head Neck Surg, 2017, 31(3): 174-179. doi: 10.13201/j.issn.1001-1781.2017.03.003

KIM-1、Cys C及β2-MG的检测对OSAHS患者早期肾功能损伤的评估及临床意义

详细信息
    通讯作者: 马建刚,E-mail:mjgent79@163.com
  • 中图分类号: R563.8

The test of KIM-1, Cys C and β2-MG to assess the early renal damage in OSAHS patients and its clinical significance

More Information
  • 目的:检测肾脏损伤因子-1(KIM-1)、胱抑素C(Cys C)及β2微球蛋白(β2-MG)在OSAHS患者中的表达水平,探索其对OSAHS患者早期肾功能损伤的评估及临床意义。方法:选取PSG监测OSAHS阳性的患者80例作为实验组,同时以OSAHS阴性者15例作为对照组,均在清晨抽取空腹静脉血检测Cys C的水平,留取中段晨尿离心后用双抗体夹心酶联免疫吸附法(ELISA)检测KIM-1的水平,所有实验数据均用SPSS13.0统计软件进行分析和比较。结果:①根据AHI变化分组检测结果:KIM-1在中度及重度患者尿中的水平高于正常人(P<0.01),Cys C、β2-MG在重度患者血中的水平均高于正常人(P<0.01),在轻度、中度、重度3组间的表达,组间两两比较,KIM-1在3组间差异均有统计学意义,Cys C、β2-MG均只在重度患者血中的水平高于轻度、中度患者(P<0.01)。②根据LSaO2变化分组检测结果:KIM-1、Cys C、β2-MG在重度组中的水平均高于正常对照组(P<0.01),在轻、中、重度3组间的表达,组间两两比较,在重度组中的水平均高于轻、中度组中的水平(P<0.01)。③KIM-1、Cys C及β2-MG组间以及与AHI之间均呈正相关(P<0.01)。④在OSAHS患者中,KIM-1、Cys C及β2-MG均与LSaO2呈负相关(P<0.01)。结论:KIM-1可以作为监测OSAHS患者早期肾功能损伤的灵敏指标,并且按照AHI分组时评价OSAHS患者早期肾功能损伤的价值优于按照LSaO2分组。
  • 加载中
  • [1]

    霍文谦,张克勤,靳风烁.肾损伤分子-1(KIM-1)与肾小管损伤研究进展[J].重庆医学,2010,39(19):2665-2667.

    [2]

    GKKUSU C A,OZDEN T A,GL H,et al.Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients[J].Clin Biochem,2004,37:94-97.

    [3]

    SHINKAI S,CHAVES P H,FUJIWARA Y,et al.Beta2-microglobulin for risk stratification of total mortality in the elderly population:comparison with cystatin C and C-reactive protein[J].Arch Intern Med,2008,168:200-206

    [4]

    蔡铁铁,冯改涛.肾脏疾病中血清β2-MG的意义[J].内蒙古医学杂志,2007,39(8):989-989.

    [5]

    IKEE R,KOBAYASHI S,HEMMI N,et al.Involvement of transglutaminase-2in pathological changes in renal disease[J].Nephron Clin Pract,2007,105:c139-146.

    [6]

    ADESEUN G A,ROSAS S E.The impact of obstructive sleep apnea on chronic kidney disease[J].Curr Hypertens Rep,2010,12:378-383.

    [7]

    BING M H,JENNUM P,MOLLER L A,et al.Obstructive sleep apnea in a Danish population of men and women aged 60-80years with nocturia[J].JClin Sleep Med,2012,8:515-520.

    [8]

    ICHIMURA T,BONVENTRE J V,BAILLY V,et a1.Kidney injury molecule-l(KIM-1),aputative epithelial cell adhesion molecule containing a novel immunoglobulin domain,is up-regulated in renal cells after injury[J].J Biol Chem,1998,273:4135-4142.

    [9]

    LIANGOS O,TIGHIOUAN H,PERIANAYAGAMM C,et al.Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass[J].Binmarkers,2009,14:423-43l.

    [10]

    VAIDYA V S,OZER J S,DIETERLE F,et al.Kidney injury molecule-1outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies[J].Nat Biotechnol,2010,28:478-485.

    [11]

    STABUC B,VRHOVEC L,STABUC-SILIH M,et al.Improved prediction of decreased reatinine clearance by serum cystatin C:use in cancer patients before and during chemotherapy[J].Clin Chem,2000,46:193-197.

    [12]

    UCHIDA K,GOTOH A.Measurement of cystatin-Cand creatinine in urine[J].Clin Chim Acta,2002,323:121-128.

    [13]

    FINNEY H,NEWMAN D J,PRICE C P.Adult reference ranges for serum cystatin C,ereatinine and predicted creatinine clearance[J].Ann Clin Biochem,2000,37:49-59.

    [14]

    HOJS R,BEVC S,EKART R,et al.Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function[J].Nephrol Dial Transplant,2006,21:1855-1862.

    [15]

    BENHR P,GRENZ A,HARTMANN J T,et al.Cystatin C-a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy[J].Kidney Blood Press Res,2006,29:32-35.

    [16]

    曾奕明,陈晓阳,黄子扬,等.模拟睡眠呼吸暂停缺氧/再氧合对小鼠心肾超微结构的影响[J].复旦学报(医学版),2006,33(1):84-88.

    [17]

    余勤,汪小亚,岳红梅,等.血清胧蛋白酶抑制剂C及尿酶对阻塞性睡眠呼吸暂停低通气综合征早期肾功能损害的诊断价值[J].兰州大学学报(医学版),2008,34(1):13-16.

    [18]

    罗国仕,涂明利,杜春玲,等.阻塞性睡眠呼吸暂停综合征患者血清胱抑素C测定及临床意义[J].郧阳医学院学报,2009,28(4):348-350.

    [19]

    CANALES M T,TAYLOR B C,ISHANI A,et al.Reduced renal function and sleep-disordered breathing in community-dwelling elderly men[J].Sleep Med,2008,9:637-645.

    [20]

    KATO K,TAKATA Y,USUI Y,et al.Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction[J].Respir Med,2011,105:643-649.

    [21]

    秦瑞香.尿α1-MG、β2-MG、A1b的检测在SLE患者早期肾损害中的意义[J].放射免疫学杂志,2005,18(3):214-214.

    [22]

    韩婧,张湘燕,夏婧,等.不同病情OSAHS患者血清Cys C与β2-MG水平变化的对比研究[J].贵州医药,2013,37(7):639-641.

  • 加载中
计量
  • 文章访问数:  439
  • PDF下载数:  511
  • 施引文献:  0
出版历程
收稿日期:  2016-10-22

目录